These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5966045)

  • 1. [Studies on several factors affecting the judgment of chemotherapeutic efficiency in pulmonary tuberculosis. 3. Evaluation of the factors in the classification of the subjects (retreatment)].
    Mitsui Y
    Saishin Igaku; 1966 Mar; 21(3):568-76. PubMed ID: 5966045
    [No Abstract]   [Full Text] [Related]  

  • 2. [Retreatment and clinical judgment based on the criteria of the Committee on Pulmonary Tuberculosis].
    Aoyagi T
    Saishin Igaku; 1966 Jan; 21(1):102-9. PubMed ID: 5965931
    [No Abstract]   [Full Text] [Related]  

  • 3. [Retreatment of lung tuberculosis].
    Iwasaki T
    Naika; 1966 Sep; 18(3):487-93. PubMed ID: 5975918
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 5. [4,4'Diisoamyloxythiocarbanilide (isoxyl) in the therapy of chronic pulmonary tuberculosis resistant to antibiotics and the usual chemotherapeutic agents. (Clinical contribution)].
    Picone A; Di Vincenzo M; Russo C
    G Ital Chemioter; 1965; 12(1):99-106. PubMed ID: 5894082
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antitubercular chemotherapy--its current status and outlook].
    Moisescu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(1):15-26. PubMed ID: 2847296
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical limits of microbial resistance to secondary antitubercular agents].
    Sakurai H; Hashimoto T
    Saishin Igaku; 1966 Jan; 21(1):88-94. PubMed ID: 5965948
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evolution of acquired drug resistance of Mycobacterium tuberculosis. Studies made in the period 1963-1965 at the Clinica Tisiologica of the University of Milan].
    Mandler F; Pradella F; Lucchini L; Ganzetti GL
    Minerva Med; 1968 Mar; 59(18):997-1001. PubMed ID: 5646215
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary tuberculosis with cavitation].
    Aoyagi T
    Naika; 1967 Nov; 20(5):908-15. PubMed ID: 5599392
    [No Abstract]   [Full Text] [Related]  

  • 10. [Follow-up studies on patients with chronic pulmonary tuberculosis treated with secondary tuberculostatic agents].
    Böszörményi M; Faust I; Barát I; Schweiger O
    Probl Tuberk; 1965; 43(8):39-45. PubMed ID: 5869918
    [No Abstract]   [Full Text] [Related]  

  • 11. [Attention on establishing retreatment regimen of pulmonary tuberculosis].
    Xiao HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):401-2. PubMed ID: 17673005
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy of tuberculosis: history and present-day status].
    Khomenko AG
    Probl Tuberk; 1996; (3):2-6. PubMed ID: 8754862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the re-treatment of pulmonary tuberculosis with special reference to resistance to primary drugs].
    Kaku R
    Kekkaku; 1968 Dec; 43(12):520-1. PubMed ID: 5716117
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of the treatment in patients with pulmonary tuberculosis excreting bacilli in primary resistance to antitubercular drugs].
    Hornung S; Polończyk M
    Gruzlica; 1965 Oct; 33(10):886-9. PubMed ID: 5881604
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tuberculosis chemotherapy in cases of resistance].
    Troi K; Marcocci S
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():477-8. PubMed ID: 6417641
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of the mycobacterial resistance to antitubercular agents in the therapeutic results of treatments of polyresistant patients].
    Jancik E; Novák M; Feitová S; Jan ciková M; Tousek J
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):325-8. PubMed ID: 5897860
    [No Abstract]   [Full Text] [Related]  

  • 17. [Classification of destructive pulmonary tuberculosis into groups according to quantitative and qualitative characteristics with the aim of developing differentiated treatment methods].
    Smirnov GA; Valiev RSh
    Probl Tuberk; 1999; (5):11-4. PubMed ID: 10565207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug resistance of Mycobacterium tuberculosis in coniotuberculosis].
    Beskrovnyĭ PS; Varenko IuS; Lastkov OA
    Vrach Delo; 1981 Aug; (8):72-4. PubMed ID: 6791383
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of tuberculosis due to resistant bacilli].
    Thibier R; Lepeuple A; Vivien JN
    Gaz Med Fr; 1965 Nov; 72(22):3895-902. PubMed ID: 5850524
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study on the re-treatment of pulmonary tuberculosis with special reference to the factors needed to be known for selecting adequate chemotherapeutic regimens].
    Kameda K
    Kekkaku; 1968 Dec; 43(12):513-5. PubMed ID: 5716114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.